Search
Search Results
##search.searchResults.foundPlural##
-
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3740PDF: 1420HTML: 6372 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2748PDF: 890HTML: 5401 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
11170PDF: 6649HTML: 21989 -
-
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2156PDF: 2045HTML: 813 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
894PDF: 593HTML: 4048 -
THE ROLE OF SERIAL RADIOGRAPHS TO DIAGNOSE DIABETIC FOOT BONE INFECTION. Serial radiographs and diabetic foot osteomyelitis
1758PDF: 814HTML: 285 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2217HTML: 1774PDF: 1226 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1530PDF: 781HTML: 1201Untitled: 230Untitled: 204Untitled: 188Untitled: 201Untitled: 212 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1454PDF: 1164HTML: 282 -
-
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2731PDF: 1266HTML: 177 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1758PDF: 977HTML: 1459Table: 252 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1910PDF: 2135Suppl. Files: 296HTML: 124 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4440PDF: 2122HTML: 1977 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2197PDF: 1128HTML: 15750COVER LETTER: 256 -
The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study
2707PDF: 1035HTML: 395 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3059PDF: 1060HTML: 7524 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4250PDF: 1347HTML: 2129Table 1: 241 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2471PDF: 1114HTML: 2435 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5386PDF: 2084HTML: 11579Fig 1: 298Fig 2: 237Fig 3: 363Fig 4: 264Fig 5: 254Fig 6: 240Fig 7: 265Fig 8: 243 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1791PDF: 645HTML: 958 -
TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES
58PDF: 27Suppl. Files: 10Html: 12Html Suppl. Files: 3 -
MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE
179PDF: 240Suppl. Files: 45Html: 121Html Suppl. Files: 109 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1466PDF: 1147HTML: 479 -
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
2061PDF: 835HTML: 260 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2518PDF: 1407HTML: 17239Bassan Fig.1: 188Bassan Fig.2: 292Bassan Fig.4: 175Fig.3: 308







